The FVRCP vaccine is a combination shot that protects cats against three serious viral infections: feline viral rhinotracheitis, calicivirus, and panleukopenia. It’s considered a core vaccine, meaning every cat should receive it regardless of whether they live indoors or outdoors. Think of it as the feline equivalent of the childhood vaccines most people get growing up.
What the Letters Stand For
Each letter in “FVRCP” maps to a different disease. FVR stands for feline viral rhinotracheitis, caused by feline herpesvirus-1. C stands for calicivirus. P stands for panleukopenia, sometimes called feline distemper. A single injection covers all three, which is why vets often refer to it simply as “the distemper shot” or “the three-in-one.”
Feline Viral Rhinotracheitis (FVR)
This is essentially a herpes infection in cats. It causes acute inflammation of the nose and eyes, usually with fever, loss of appetite, and depression. Cats develop sneezing, nasal congestion, and watery or crusty eye discharge. Some develop corneal ulcers that can threaten their vision.
The tricky part is that nearly all cats are exposed to this virus at some point, and once infected, most become lifelong carriers. The virus goes dormant after the initial illness but can reactivate during periods of stress, illness, or immune suppression. When it reactivates, the cat sheds the virus and can infect other cats. Vaccination doesn’t prevent a cat from carrying the virus, but it significantly reduces the severity of symptoms during both initial infection and flare-ups.
Calicivirus (C)
Calicivirus starts out looking like a bad cold: sneezing, nasal congestion, fever, sometimes drooling. Heavy discharge can pour from the eyes and nose. In more severe cases, cats develop painful ulcers on the tongue and the lining of the mouth, along with lameness and loss of appetite. Most cats recover fully, but some go on to develop chronic gum inflammation that makes eating painful for the rest of their lives.
A rare but dangerous form called virulent systemic calicivirus (FCV-VSD) can cause high fever, swelling of the head and legs, crusting sores, hair loss around the face and paws, liver damage, and internal bleeding. This form has a much higher fatality rate than typical calicivirus.
The virus spreads through direct contact with an infected cat’s saliva, nasal mucus, and eye discharge, and through sneeze droplets in the air. It also survives on surfaces like food bowls, litter boxes, and bedding for up to a month. People who handle an infected cat can carry the virus on their hands and clothing to other animals.
Panleukopenia (P)
Panleukopenia is the most dangerous of the three diseases. It attacks rapidly dividing cells, particularly in the gut lining and bone marrow, causing a dramatic drop in white blood cells (which is what “panleukopenia” literally means). Symptoms include severe depression, relentless vomiting, bloody diarrhea, and rapid dehydration. The mortality rate for acute panleukopenia ranges from 25% to 90%, and the most severe form can be fatal in nearly 100% of cases.
The virus spreads through the fecal-oral route and flea bites. It’s extraordinarily tough, surviving up to a year in contaminated environments. An indoor-only cat can be exposed if someone tracks the virus in on shoes or clothing. Kittens and unvaccinated young cats are at the highest risk, which is why early vaccination is so important.
When Cats Get Vaccinated
Kittens typically start the FVRCP series at around 6 to 8 weeks of age, with booster doses given every 3 to 4 weeks until they’re about 16 weeks old. This series is necessary because antibodies from the mother’s milk gradually fade, and multiple doses ensure the kitten builds its own immunity during that transition.
After the initial kitten series, a booster is given one year later. From that point on, the American Animal Hospital Association recommends revaccination every three years for the injectable form. Cats that receive the intranasal version (a spray delivered into the nose) need annual boosters instead.
For cats heading into boarding facilities or other high-exposure situations, a booster 7 to 10 days beforehand can be helpful, especially if the cat hasn’t been vaccinated in the past year. The intranasal version provides faster protection, which makes it particularly useful in shelters and for kittens in high-risk environments.
Modified Live vs. Inactivated Vaccines
FVRCP vaccines come in two main types. Modified live vaccines use a weakened version of each virus that can still replicate enough to trigger a strong immune response. Inactivated (killed) vaccines use virus particles that can’t replicate and typically include an adjuvant, a substance that boosts the immune response.
In clinical testing, both types produce similar overall protection. One study found no statistical difference in total clinical scores between cats vaccinated with either type when later exposed to feline herpesvirus. Interestingly, the inactivated vaccine produced significantly fewer respiratory signs after challenge than the modified live version, though overall disease severity was comparable. Both types showed protective effects as early as 7 days after vaccination.
Modified live vaccines tend to generate a faster, more robust immune response, which is why many vets prefer them for kittens and cats in high-risk settings. Inactivated vaccines are sometimes chosen for pregnant cats or cats with compromised immune systems, since there’s no risk of the weakened virus causing illness.
Side Effects and Safety
The FVRCP vaccine has a strong safety record. Adverse reactions within 30 days of vaccination occur at a rate of about 0.52% of vaccinated cats. The most common reactions are mild: lethargy, reduced appetite, and low-grade fever for a few days, or minor swelling at the injection site. In one study, about 10% of vaccinated cats developed a slightly reduced general condition for a few days, which actually correlated with a stronger antibody response, suggesting the immune system was doing its job.
The most serious potential complication is feline injection-site sarcoma (FISS), a type of tumor that can develop at the location where a vaccine was given. This is rare, estimated at 1 to 4 cases per 10,000 vaccinated cats in the United States. While originally linked mainly to rabies and feline leukemia vaccines, FVRCP vaccines have also been identified as a possible trigger in some cases. To minimize risk, vets now follow standardized injection-site guidelines, giving vaccines in specific locations on the legs or tail rather than between the shoulder blades. If you notice a lump at a vaccination site that persists for more than three weeks, grows larger than 2 centimeters, or continues to increase in size a month after vaccination, have your vet examine it.
Why Indoor Cats Still Need It
The panleukopenia virus can survive on surfaces for up to a year, meaning it can hitch a ride into your home on shoes, bags, or clothing. Calicivirus persists on surfaces for up to a month. New cats brought into the household, even briefly, can carry feline herpesvirus without showing any symptoms. Windows and screen doors can allow nose-to-nose contact with neighborhood cats. Indoor cats that escape, even once, are immediately vulnerable if they haven’t been vaccinated. The relatively low cost and excellent safety profile of the vaccine makes skipping it a gamble with very little upside.